Recurrent Childhood Acute Lymphoblastic Leukemia Completed Phase 2 Trials for Treosulfan (DB11678)

IndicationStatusPhase
DBCOND0028597 (Recurrent Childhood Acute Lymphoblastic Leukemia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00860574Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic LeukemiaTreatment